All data are based on the daily closing price as of November 24, 2025
c
Chong Kun Dang Pharmaceutical
185750.KO
57.49 USD
-0.09
-0.16%
Overview
Last close
57.49 usd
Market cap
757.44M usd
52 week high
90.07 usd
52 week low
48.18 usd
Target price
76.42 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.6686
Price/Book Value
1.1866
Enterprise Value
749.18M usd
EV/Revenue
0.6582
EV/EBITDA
2.7561
Key financials
Revenue TTM
1.14B usd
Gross Profit TTM
356.45M usd
EBITDA TTM
72.93M usd
Earnings per Share
N/A usd
Dividend
0.74 usd
Total assets
1.09B usd
Net debt
N/A usd
About
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.